vTv Therapeutics Inc. Quarterly Current Ratio in % from Q2 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
vTv Therapeutics Inc. quarterly Current Ratio history and growth rate from Q2 2016 to Q3 2024.
  • vTv Therapeutics Inc. Current Ratio for the quarter ending September 30, 2024 was 466 %, a 133% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 466 +266 +133% Sep 30, 2024
Q2 2024 328 +54.3 +19.8% Jun 30, 2024
Q1 2024 227 -92.9 -29.1% Mar 31, 2024
Q4 2023 143 -123 -46.2% Dec 31, 2023
Q3 2023 201 -29.8 -12.9% Sep 30, 2023
Q2 2023 274 +49.6 +22.1% Jun 30, 2023
Q1 2023 319 +122 +61.9% Mar 31, 2023
Q4 2022 266 +25 +10.4% Dec 31, 2022
Q3 2022 230 +4.77 +2.12% Sep 30, 2022
Q2 2022 224 +98.5 +78.2% Jun 30, 2022
Q1 2022 197 +111 +129% Mar 31, 2022
Q4 2021 241 +185 +333% Dec 31, 2021
Q3 2021 225 +188 +505% Sep 30, 2021
Q2 2021 126 +93.4 +287% Jun 30, 2021
Q1 2021 86 +62 +258% Mar 31, 2021
Q4 2020 55.6 +30.2 +119% Dec 31, 2020
Q3 2020 37.3 +13 +53.7% Sep 30, 2020
Q2 2020 32.6 +8.7 +36.5% Jun 30, 2020
Q1 2020 24 +1.48 +6.56% Mar 31, 2020
Q4 2019 25.4 +1.12 +4.62% Dec 31, 2019
Q3 2019 24.3 -13.5 -35.8% Sep 30, 2019
Q2 2019 23.9 -35 -59.4% Jun 30, 2019
Q1 2019 22.6 -86.9 -79.4% Mar 31, 2019
Q4 2018 24.3 -172 -87.7% Dec 31, 2018
Q3 2018 37.8 -294 -88.6% Sep 30, 2018
Q2 2018 58.8 -354 -85.8% Jun 30, 2018
Q1 2018 109 -390 -78.1% Mar 31, 2018
Q4 2017 197 -409 -67.6% Dec 31, 2017
Q3 2017 332 -436 -56.8% Sep 30, 2017
Q2 2017 413 -603 -59.4% Jun 30, 2017
Q1 2017 499 Mar 31, 2017
Q4 2016 606 Dec 31, 2016
Q3 2016 768 Sep 30, 2016
Q2 2016 1.02K Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.